DSIJ Mindshare

Suven Life Sciences surges on securing product patents

Nidhi Jani 0 704 Article rating: 5.0

Suven Life Sciences, a biopharmaceutical company, surges by almost 3 per cent as it has secured product patents in Brazil and Eurasia for the treatment of neurodegenerative diseases. The product patent acquired by the company in Brazil will be valid through 2023, while the product patent acquired in Eurasia will be valid through 2024.


RSS
First53405341534253435345534753485349Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR